Literature DB >> 26227194

Improved Detection of Cardiac Allograft Vasculopathy: A Multi-Institutional Analysis of Functional Parameters in Pediatric Heart Transplant Recipients.

Steven J Kindel1, Yuk M Law2, Clifford Chin3, Michael Burch4, James K Kirklin5, David C Naftel5, Elizabeth Pruitt5, Michael P Carboni6, Anna Arens7, Andrew M Atz8, William J Dreyer9, William T Mahle10, Elfriede Pahl7.   

Abstract

BACKGROUND: Recent guidelines recommend assessment of systolic function and filling pressures to augment angiographic grading of cardiac allograft vasculopathy (CAV); however, no data exist on the utility of these guidelines.
OBJECTIVES: The aims of this study were to evaluate whether the assessment of systolic and diastolic graft function, in addition to angiography, improves recognition of patients at high risk of graft loss and to assess the ability of adult filling-pressure thresholds to discriminate graft dysfunction in pediatric patients.
METHODS: This study reviewed Pediatric Heart Transplant Study data from 1993 to 2009. Graft dysfunction was defined as significant systolic dysfunction (ejection fraction [EF] <45%) or the presence of restrictive hemodynamic features. Additional pediatric hemodynamic cutpoints of right atrial pressure (RAP) >12 mm Hg or pulmonary capillary wedge pressure (PCWP) >15 mm Hg were analyzed.
RESULTS: In the study, 8,122 angiograms were performed in 3,120 patients, and 70% of patients had at least 1 angiogram. Angiographic incidence of CAV was 5%, 15%, and 28% at 2, 5, and 10 years, respectively, and most disease was mild. The presence of graft dysfunction identified patients at greater risk for graft loss even in children with mild angiographic vasculopathy (p < 0.0001). An RAP >12 mm Hg or a PCWP >15 mm Hg was sufficient to detect patients at high risk of graft loss even with mild angiographic disease.
CONCLUSIONS: Patients with only mild angiographic CAV have significantly better outcomes than do patients with moderate or severe disease. The presence of an EF <45%, an RAP >12 mm Hg, or a PCWP >15 mm Hg identifies children at increased risk of graft loss even in the presence of only mild angiographic vasculopathy.
Copyright © 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  chronic rejection; coronary artery; graft loss; heart transplant; hemodynamics; vasculopathy

Mesh:

Year:  2015        PMID: 26227194     DOI: 10.1016/j.jacc.2015.05.063

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  8 in total

1.  Elevated serum vascular endothelial growth factor and development of cardiac allograft vasculopathy in children.

Authors:  Kae Watanabe; Anis Karimpour-Fard; Alix Michael; Shelley D Miyamoto; Stephanie J Nakano
Journal:  J Heart Lung Transplant       Date:  2018-04-30       Impact factor: 10.247

2.  Diagnostic and prognostic value of myocardial blood flow quantification as non-invasive indicator of cardiac allograft vasculopathy.

Authors:  Paco E Bravo; Brian A Bergmark; Tomas Vita; Viviany R Taqueti; Ankur Gupta; Sara Seidelmann; Thomas E Christensen; Michael T Osborne; Nishant R Shah; Nina Ghosh; Jon Hainer; Courtney F Bibbo; Meagan Harrington; Fred Costantino; Mandeep R Mehra; Sharmila Dorbala; Ron Blankstein; Akshay Desai; Lynne Stevenson; Michael M Givertz; Marcelo F Di Carli
Journal:  Eur Heart J       Date:  2018-01-21       Impact factor: 29.983

Review 3.  Current state of pediatric cardiac transplantation.

Authors:  Anne I Dipchand
Journal:  Ann Cardiothorac Surg       Date:  2018-01

4.  Vascular endothelial growth factor A is associated with the subsequent development of moderate or severe cardiac allograft vasculopathy in pediatric heart transplant recipients.

Authors:  Kevin P Daly; Maria Stack; Michele F Eisenga; John F Keane; David Zurakowski; Elizabeth D Blume; David M Briscoe
Journal:  J Heart Lung Transplant       Date:  2016-10-03       Impact factor: 10.247

Review 5.  Therapeutic Approaches in Heart Failure with Preserved Ejection Fraction (HFpEF) in Children: Present and Future.

Authors:  Bibhuti B Das
Journal:  Paediatr Drugs       Date:  2022-05-02       Impact factor: 3.022

6.  Increased mortality, morbidities, and costs after heart transplantation in heterotaxy syndrome and other complex situs arrangements.

Authors:  Son Q Duong; Justin Godown; Jonathan H Soslow; Cary Thurm; Matt Hall; Sandeep Sainathan; Victor O Morell; Debra A Dodd; Brian Feingold
Journal:  J Thorac Cardiovasc Surg       Date:  2018-11-16       Impact factor: 5.209

7.  Cardiovascular health in pediatric heart transplant patients.

Authors:  Carmel Bogle; Amanda Marma Perak; Sarah J Wilkens; Alaa Aljiffry; Karen Rychlik; John M Costello; Donald M Lloyd-Jones; Elfriede Pahl
Journal:  BMC Cardiovasc Disord       Date:  2022-04-01       Impact factor: 2.298

8.  Nuclear Imaging in Pediatric Cardiology: Principles and Applications.

Authors:  Maelys Venet; Mark K Friedberg; Luc Mertens; Jerome Baranger; Zakaria Jalal; Ghoufrane Tlili; Olivier Villemain
Journal:  Front Pediatr       Date:  2022-07-06       Impact factor: 3.569

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.